Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001245103 | SCV001418369 | likely benign | not provided | 2024-10-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001245103 | SCV004157475 | likely benign | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | EYS: BP4 |
Ambry Genetics | RCV005340724 | SCV005999253 | uncertain significance | Inborn genetic diseases | 2024-12-31 | criteria provided, single submitter | clinical testing | The c.9185A>G (p.N3062S) alteration is located in exon 43 (coding exon 40) of the EYS gene. This alteration results from a A to G substitution at nucleotide position 9185, causing the asparagine (N) at amino acid position 3062 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001278441 | SCV001465454 | uncertain significance | Autosomal recessive retinitis pigmentosa | 2020-07-25 | no assertion criteria provided | clinical testing |